(NYSE:FCX), SAN DIEGO, Dec. 05, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Freeport-McMoRan Inc. (NYSE: FCX) publicly traded securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”), have until Monday, January 12, 2026 to seek appointment as lead plaintiff of the Freeport-McMoRan […]

FCX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Freeport McMoRan Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit GlobeNewswire December 06, 2025 SAN DIEGO, Dec. 05, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Freeport-McMoRan Inc. (NYSE: FCX) publicly

(HKSE:1877.HK),(Shenzhen:688180.SS), Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab plus chemotherapy as 1st-line treatment for R/M NPC, achieving mOS of 64.8 months and a 5-year OS rate of 52.3%. Torpalimab plus chemotherapy has been approved in over 40 countries, representing the new standard of care for the 1st

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients GlobeNewswire December 06, 2025 Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab plus chemotherapy as 1st-line treatment for R/M NPC, achieving mOS of 64.8 months and a 5-year OS rate

SRN Advisors, LLC (SRN) announced today that the Siren DIVCON Dividend Defender ETF (CBOE: DFND), an index-based exchange-traded fund (“ETF”) managed by SRN, will reorganize into and with the Siren DIVCON Leaders Dividend ETF (CBOE: LEAD) (the “Funds”), also an index-based ETF managed by SRN. The reorganization was approved by the Board of Trustees (the

Bozen, Italy–(Newsfile Corp. – December 5, 2025) – Transfeero ends 2025 as one of the strongest years in its history, solidifying its position as a leading global provider of private transportation services. The platform designed to connect travelers seeking reliable and convenient mobility solutions with a worldwide network of professional drivers and licensed transport companies

Product:Sweet and Savory Mix Issue: Food – Microbial contamination – Salmonella Distribution:Ontario Online link SOURCE Canadian Food Inspection Agency (CFIA) https://rt.newswire.ca/rt.gif?NewsItemId=C3672&Transmission_Id=202512052104CANADANWWEB______C3672&DateId=20251205

PCs FOR PEOPLE announced today that Cofounder and CEO, Casey Sorensen, is departing from his role effective December 26, 2025. Sorensen, with the nonprofit since 2008, turned a simple idea of getting computers to low-income families into a self-sustaining model, where each region funds its own start-up costs. “Casey worked tirelessly to shape PCs for

Phase 2 results selected as one of only 10 featured presentations in the Poster Tour at the 2025 Parkinson Study Group (PSG) Annual Meeting Pivotal Phase 3 ARISE trial evaluating solengepras as an adjunctive treatment in Parkinson's disease is underway and actively enrolling patients BOSTON, Dec. 05, 2025 (GLOBE NEWSWIRE) — Cerevance, a clinical-stage biopharmaceutical

Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson's Disease GlobeNewswire December 06, 2025 Phase 2 results selected as one of only 10 featured presentations in the Poster Tour at the 2025 Parkinson Study Group (PSG) Annual Meeting Pivotal Phase 3 ARISE trial evaluating